Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies

BACKGROUND: Genomic aberrations can be used to determine cancer diagnosis and prognosis. Clinically relevant novel aberrations can be discovered using high-throughput assays such as Single Nucleotide Polymorphism (SNP) arrays and next-generation sequencing, which typically provide aggregate signals...

Descripción completa

Detalles Bibliográficos
Autores principales: Parisi, Fabio, Ariyan, Stephan, Narayan, Deepak, Bacchiocchi, Antonella, Hoyt, Kathleen, Cheng, Elaine, Xu, Fang, Li, Peining, Halaban, Ruth, Kluger, Yuval
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114747/
https://www.ncbi.nlm.nih.gov/pubmed/21569352
http://dx.doi.org/10.1186/1471-2164-12-230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114747/
https://www.ncbi.nlm.nih.gov/pubmed/21569352
http://dx.doi.org/10.1186/1471-2164-12-230

Ejemplares similares